Shankara Biochem Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 25 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -74.63%
- Profit Growth 253.33%
- Ebitda 247.00%
- Net Worth 74.81%
- Total Assets -93.24%
About Shankara Biochem
Shankara Biochem Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 October 1999 and has a history of 25 years and four months. Its registered office is in New Delhi, Delhi, India.
The Corporate was formerly known as Virtual Data Private Limited. The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arpit Wason and Priyanka Singhal serve as directors at the Company.
Company Details
-
Location
New Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U09211DL1999PTC101902
-
Company No.
101902
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Oct 1999
-
Date of AGM
28 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Shankara Biochem Private Limited offer?
Shankara Biochem Private Limited offers a wide range of products and services, including Hand Sanitizer & Disinfectant, Alcohol Based Hand Sanitizer, Food Enzymes, Protease, Confectionery Ingredients, Bread Improvers, Flavours & Aromatics, Food Stabilizer, Dough Conditioners, Bakery & Confectionery Products.
Who are the key members and board of directors at Shankara Biochem?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arpit Wason
|
Director | 21-Aug-2023 | Current |
|
Priyanka Singhal
|
Director | 24-Sep-2019 | Current |
Financial Performance of Shankara Biochem.
Shankara Biochem Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 74.63% decrease. The company also saw a substantial improvement in profitability, with a 253.33% increase in profit. The company's net worth Soared by an impressive increase of 74.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shankara Biochem?
In 2023, Shankara Biochem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shankara Biochem?
Unlock and access historical data on people associated with Shankara Biochem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shankara Biochem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shankara Biochem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
